Y300-3305 Screening compound: N-methyl-N-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide

Y300-3305 Screening compound: N-methyl-N-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide
Y300-3305 Screening compound: N-methyl-N-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y300-3305
N-methyl-N-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y300-3305

Molecular Formula

C23H26N4O3 (C23 H26 N4 O3)

Compound Name

N-methyl-N-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide

IUPAC name

N-methyl-N-{[3-(4-methylphenyl)-124-oxadiazol-5-yl]methyl}-4-[(morpholin-4-yl)methyl]benzamide

SMILES

Cc(cc1)ccc1-c1noc(CN(C)C(c2ccc(CN3CCOCC3)cc2)=O)n1

InChI

InChI=1S/C23H26N4O3/c1-17-3-7-19(8-4-17)22-24-21(30-25-22)16-26(2)23(28)20-9-5-18(6-10-20)15-27-11-13-29-14-12-27/h3-10H,11-16H2,1-2H3

InChI Key

OFAILIMJGSUMDL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD22441602

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.950

Distribution Coefficient, logD

2.909

Water Solubility, LogSw

-2.90

Polar Surface Area

59.373

Acid Dissociation Constant (pKa)

27.95

Base Dissociation Constant (pKb)

6.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

Y300-3305 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y300-3305 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y300-3305?
Check Price and Availability of Y300-3305, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y300-3305 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y300-3305
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y300-3305
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y300-3305 available by request